Preparation and characterization of a specific monoclonal antibody against CIAPIN1

Area of Science:

• Molecular Biology
• Oncology

Background:

• Cytokine-induced antiapoptosis inhibitor 1 (CIAPIN1) is a newly identified molecule involved in apoptosis.
• CIAPIN1 is implicated as a mediator in multidrug resistance (MDR) in gastric cancer.

Purpose of the Study:

• To clone human CIAPIN1 and generate a monoclonal antibody (MAb) against it.
• To characterize the generated MAb for its ability to detect CIAPIN1 protein.
• To investigate the expression of CIAPIN1 in multidrug-resistant gastric cancer cell lines.

Main Methods:

• Cloning of human CIAPIN1 cDNA using RT-PCR.
• Construction and expression of prokaryotic fusion proteins (pET28-a(+) and pGEX-4T-1).
• Purification of fusion proteins via affinity chromatography.
• Generation of monoclonal antibody using standard cell fusion and ELISA screening.
• Validation of MAb specificity using immunohistochemistry and Western blot.
• Analysis of CIAPIN1 expression in gastric cancer cell lines via Western blotting.

Main Results:

• Successfully cloned human CIAPIN1 and constructed expression vectors.
• Expressed and purified human CIAPIN1 fusion proteins in E. coli.
• Developed a monoclonal antibody that recognizes both native and denatured human and mouse CIAPIN1.
• Confirmed upregulation of CIAPIN1 expression in multidrug-resistant gastric cancer cell lines.

Conclusions:

• A specific monoclonal antibody against CIAPIN1 has been successfully generated.
• This MAb is a valuable tool for detecting CIAPIN1 protein.
• CIAPIN1 is upregulated in multidrug-resistant gastric cancer, suggesting its role in MDR.